Since the beginning of the pandemic, a great body of knowledge has shown that poor outcomes in hospitalized COVID-19 patients are associated with biomarkers like decreased lymphocyte and platelet count, elevated C reactive protein, procalcitonin, D-dimer, lactate dehydrogenase, aminotransferases, creatine kinase, and creatinine levels [51,52,53]. The gene discussed is CRP; the disease is COVID-19.